Skip to main content
Novonesis AS logo

Novonesis AS — Investor Relations & Filings

Ticker · NSIS ISIN · DK0060336014 LEI · 529900T6WNZXD2R3JW38 CO Manufacturing
Open in API
Filings indexed 2,308 across all filing types
Latest filing 2011-12-12 Regulatory Filings
Country DK Denmark
Listing CO NSIS

About Novonesis AS

https://www.novozymes.com/en

Novonesis is a global biosolutions company formed through the combination of Novozymes and Chr. Hansen. The company develops and produces a broad portfolio of biological solutions, including industrial enzymes, functional proteins, and microorganisms such as cultures, probiotics, and yeast. Its products are utilized in over 30 industries to improve efficiency, sustainability, and product quality. Key markets include food and beverage, where solutions enhance nutrition and reduce waste; human and animal health; agriculture, promoting higher crop yields and animal welfare; and household care, for more effective cleaning. Novonesis applies biotechnological principles to address global challenges in production and consumption, aiming to create more sustainable systems and products.

Recent filings

Filing Released Lang Actions
Regulatory Filings 2011
Regulatory Filings
2011-12-12 Danish
Regulatory Filings 2011
Regulatory Filings
2011-12-01 Danish
Director's Dealing 2011
Director's Dealing Classification · 99% confidence The document is a short official announcement from Novozymes, dated December 2011, detailing a transaction made by a senior executive (Steen Riisgaard, CEO) involving the sale of company shares. The structure includes a table detailing the trade (date, type, size, value) and references Danish securities law ('Værdipapirhandelslovens paragraf 28a'). This specific reporting requirement for insider transactions by directors and executives directly maps to the 'Director's Dealing' category. The document length is very short (1775 chars), but it is the primary report of the transaction itself, not an announcement of a different report, so the RPA/RNS rule does not apply here. Therefore, the classification is DIRS.
2011-12-01 English
Report Publication Announcement 2011
Report Publication Announcement Classification · 99% confidence The document text is extremely short ("Læs hele meddelelsen," which translates to "Read the whole announcement" in Danish) and contains no specific financial or regulatory keywords (like 10-K, Earnings, Dividend, etc.). Given the minimal content and the instruction to read the full message, this strongly suggests the provided text is merely a placeholder or a link/title for a larger document, fitting the criteria for a Report Publication Announcement (RPA) or a general Regulatory Filing (RNS) under the 'MENU VS MEAL' rule. Since there is no context about *what* report is being published, RNS is the most appropriate general fallback for an unclassifiable, minimal regulatory notice.
2011-11-29 Danish
Director's Dealing 2011
Director's Dealing Classification · 99% confidence The document is a short official announcement dated November 29, 2011, detailing a specific transaction made by a director ('Steen Riisgaard, Administrerende Direktør') involving the company's shares (Novozymes B-aktier). The table explicitly shows the transaction character as 'Udnyttelse af Optioner (køb af aktier)' (Exercise of Options (purchase of shares)) and lists the director's relation to the company. This directly corresponds to the definition of Director's Dealing (insider trades). Filing Category: Director's Dealing (Code: DIRS). The document length is short (1837 chars), but it is the primary disclosure of the trade itself, not an announcement of a report, thus DIRS is appropriate over RPA or RNS.
2011-11-29 English
Share Issue/Capital Change 2011
Share Issue/Capital Change Classification · 99% confidence The document text is extremely short (63 characters) and contains Danish text translating to 'Information about share split Novozymes A/S' followed by 'Read the entire announcement'. This strongly suggests the document is not the detailed filing itself but rather a brief announcement stating that more information (likely about a share split) is available elsewhere. A share split falls under capital structure changes. The most specific category for capital structure changes is 'Share Issue/Capital Change' (SHA). However, given the brevity and the instruction to read the full announcement, it fits the 'Report Publication Announcement' (RPA) criteria if it's announcing the release of the detailed filing, or potentially 'Regulatory Filings' (RNS) if it's a very brief mandatory notice. Since a share split is a specific capital event, SHA is the intended target for the underlying information. But based on the 'MENU VS MEAL' rule, this short notice announcing the availability of the full details points towards RPA or RNS. Given that a share split is a specific corporate action, RPA is a better fit than the general RNS fallback, as it announces the publication of information related to a specific event.
2011-11-22 Danish

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.